Restricted Field IMRT Dramatically Enhances IMRT Planning for Mesothelioma

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 5, 2007, Pages 1587-1592

  Allen, Aaron M ^a   Schofield, Deborah ^a   Hacker, Fred ^a   Court, Laurence E ^a   Czerminska, Maria ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

IMRT; Intensity modulated radiotherapy; Mesothelioma; Optimization

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; DRUG DOSAGE; ONCOLOGY;

INTENSITY-MODULATED RADIOTHERAPY; MESOTHELIOMA;

RADIOTHERAPY;

ARTICLE; CANCER PATIENT; COHORT ANALYSIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG RESECTION; MESOTHELIOMA; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE DISTRIBUTION; TECHNIQUE; TREATMENT PLANNING;

HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 36148981802     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.075     Document Type: Article

References (21)

1. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis: Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
2. Sugarbaker D.J., Strauss G.M., Lynch T.J., et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 11 (1993) 1172-1178
3. Rusch V.W., Piantadosi S., and Holmes E.C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 102 (1991) 1-9
4. Yajnik S., Rosenzweig K.E., Mychalczak B., et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 56 (2003) 1319-1326
5. Baldini E.H., Recht A., Strauss G.M., et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63 (1997) 334-338
6. Allen A.D., Wong R., Zurakowski J.S., et al. The influence of radiotherapy technique and dose on the patterns of failure for mesothelioma patients following extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys 68 (2007) 1366-1374
7. Ahamad A., Stevens C.W., Smythe W.R., et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55 (2003) 768-775
8. Ahamad A., Stevens C.W., Smythe W.R., et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9 (2003) 476-484
9. Forster K.M., Smythe W.R., Starkschall G., et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: Clinical implementation. Int J Radiat Oncol Biol Phys 55 (2003) 606-616
10. Allen A.M., Czerminska M., Janne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65 (2006) 640-645
11. Komaki R., Liao Z., Liu H., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: In regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645). [Letter]. Int J Radiat Oncol Biol Phys 66 (2006) 1595-1596
12. Chan M.F., Chui C.S., Song Y., et al. A novel radiation therapy technique for malignant pleural mesothelioma combining electrons with intensity-modulated photons. Radiother Oncol 79 (2006) 218-223
13. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
14. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
15. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
16. De Neve W., and De Wagter C. Lethal pneumonitis in a phase I study of chemotherapy and IMRT for NSCLC: The need to investigate the accuracy of dose computation. Radiother Oncol 75 (2005) 246-247
17. Holloway C.L., Robinson D., Murray B., et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 73 (2004) 285-287
18. Murshed H., Liu H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1258-1267
19. Liu H.H., Jauregui M., Zhang X., et al. Beam angle optimization and reduction for intensity-modulated radiation therapy of non-small-cell lung cancers. Int J Radiat Oncol Biol Phys 65 (2006) 561-572
20. Pugachev A., and Xing L. Incorporating prior knowledge into beam orientation optimization in IMRT. Int J Radiat Oncol Biol Phys 54 (2002) 1565-1574
21. Jang S.Y., Liu H.H., Wang X., et al. Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte-Carlo approaches. Int J Radiat Oncol Biol Phys 66 (2006) 939-948